Remove Government Remove Pharmaceutical Remove Promotion
article thumbnail

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

Mad in America

For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Was it related to medical insurance or government programs? What Mad in America can do is keep on promoting and publishing this information.

article thumbnail

Irish Psychiatry Says Chemical Imbalance Is a Figure of Speech—So, What Now?

Mad in America

Published in the British Medical Journal (BMJ), 30+ prominent figures called on the UK government to acknowledge the evidence that antidepressants are no better than placebos for most patients and to increase funding of social and psychological interventions while decreasing drug prescriptions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Maudsley Deprescribing Guidelines: An Interview with David Taylor and Mark Horowitz

Mad in America

He is also a current member of the UK government’s Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. The NICE guidelines, which are the government guidelines in England, adopted our approach.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

In these interviews, I have talked about the components of the psychiatric-pharmaceutical-industrial complex, along with how psychiatry meets the political needs of the ruling class and dysfunctional families. Mainstream media is another major player in the psychiatric-pharmaceutical-industrial complex. Evolutionary geneticist R.C.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.

article thumbnail

The Iatrogenic Gaze: How We Forgot That Psychiatry Could Be Harmful

Mad in America

Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.

article thumbnail

Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History

Mad in America

You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. It is, though, largely funded by the government.